您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
NA/LE Mouse anti-human CD3 mAb

NA/LE Mouse anti-human CD3 mAb

货号: S0B0009
价格: 960
规格: 1mg
介绍: -
其他: -
产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD3
  • 分子别名

    T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, T3E
  • 免疫原

    N/A
  • Accession

    P07766
  • 克隆号

    OKT3
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2a,k
  • 同型对照

    Invivo mouse IgG2a isotype control
  • 应用

    in vitro T cell stimulation/activation, Functional Assay, FC
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    Lot specific* (generally 0.5 to 5 mg/ml)*
  • 内毒素含量

    <1EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative
  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;

    -20 °C for 3 months under sterile conditions; 

    -80 °C for 24 months under sterile conditions.

    Please avoid repeated freeze-thaw cycles.

稀释度
应用 稀释度
Functional Assay 1:500
FC 1:500
背景介绍
  • This antibody recognizes the same epitope as  clone  OKT3.

    CD3 (cluster of differentiation 3) is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell (CD8+ naive T cells) and T helper cells (CD4+ naive T cells). It is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. These chains associate with the T-cell receptor (TCR) and the CD3-zeta (ζ-chain) to generate an activation signal in T lymphocytes. The TCR, CD3-zeta, and the other CD3 molecules together constitute the TCR complex. The CD3–T cell receptor (TCR) complex plays a central role in the T-cell-mediated immunoresponse as it is involved in the recognition of antigens and subsequent signal transduction and activation of immunocompetent T lymphocytes. Because CD3 is required for T cell activation, drugs (often monoclonal antibodies) that target it are being investigated as immunosuppressant therapies (e.g., otelixizumab, teplizumab) for type 1 diabetes and other autoimmune diseases.

  • 组分和操作说明

    • Procedure

      1. Isolate human PBMCs according to the manufacturer’s instructions.

      2. Suspend PBMCs in medium at 106 cells/mL.

      3. Do one of the following depending on the format you are using:

      · For the soluble format, incubate 106 cells with CD3 Mouse mAb (OKT3) at 1 µg/mL final concentration in culture for 3 days (5% CO2, 37°C).

      · For the immobilized format, coat the CD3 Mouse mAb (OKT3) onto a plate at 5 to 10 μg/mL at 4°C, overnight. Add cells to the CD3 Mouse mAb (OKT3)-coated plate.

      4. Wash the cells twice and resuspend them in medium at 106 cells/mL.

      5. Distribute the cells in a round-bottom plate at 105 cells per well.

      6. [Optional for co-stimulation] Add CD28 Mouse mAb (15E8) and optionally Protein G at 5 µg/mL each final concentration, and incubate the plate for an additional 3 days (5% CO2 at 37°C).
  • 验证数据

    • Flow cytometric analysis of Human peripheral blood mononuclear cells (PBMC) labeling CD3 with purified antibody at 1/500 dilution (0.1 μg) (Right) compared with a Rabbit monoclonal IgG isotype control (Left). Goat Anti-Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. 

      Cells were surface stained with CD19-Alexa Fluor® 647, then stained with rabbit IgG (Left) / anti-CD3 (Right) separately. CD3 and CD19 are mutually exclusive expressed in human PBMCs. Gated on total viable cells.

    • T cell proliferation Assay with CD3(S0B0009) &CD28 (S0B0010)

    • T cell proliferation Assay with CD3(S0B0009) &CD28 (S0B0010)